Clinical, Pathologic Characteristics and Survival Of Adult Patients With Essential Thrombocythemia: Experience In a Reference Center In Mexico

Essential thrombocythemia (ET) is a myeloproliferative neoplasm, characterized by sustained thrombocytosis (≥450 x 109/L), vasomotor symptoms and thrombotic / hemorrhagic complications. Treatment and prognosis relies on risk stratification, based on age and thrombosis history. Survival is similar to that of general population, however there is a low risk of transformation to myelofibrosis (MF) and acute myeloid leukemia (AML).